Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Duchenne muscular dystrophy.

J S Chamberlain1

  • 1Department of Human Genetics, University of Michigan Medical School, Ann Arbor 48190-0618.

Current Opinion in Genetics & Development
|June 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heparin-binding correlates with increased efficiency of AAV1- and AAV6-mediated transduction of striated muscle, but negatively impacts CNS transduction.

Gene therapy·2012
Same author

Microarchitecture is severely compromised but motor protein function is preserved in dystrophic mdx skeletal muscle.

Biophysical journal·2010
Same author

Unloaded speed of shortening in voltage-clamped intact skeletal muscle fibers from wt, mdx, and transgenic minidystrophin mice using a novel high-speed acquisition system.

Biophysical journal·2008
Same author

Gene therapy for Duchenne muscular dystrophy: AAV leads the way.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2006
Same author

Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.

Gene therapy·2005
Same author

Characterization of ARC, apoptosis repressor interacting with CARD, in normal and dystrophin-deficient skeletal muscle.

Human molecular genetics·2003

Understanding dystrophin offers new treatment hope for Duchenne muscular dystrophy. Simple molecular methods have also significantly improved disease diagnosis, advancing patient care.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Duchenne muscular dystrophy (DMD) is a severe genetic disorder.
  • Dystrophin protein deficiency is central to DMD pathogenesis.
  • Current treatment options for DMD are limited.

Purpose of the Study:

  • To highlight recent advancements in understanding dystrophin's role in DMD.
  • To discuss improvements in molecular diagnostic techniques for DMD.

Main Methods:

  • Review of current scientific literature on dystrophin and DMD.
  • Analysis of novel molecular diagnostic approaches for DMD.

Main Results:

  • Progress in dystrophin research provides potential therapeutic targets.

Related Experiment Videos

  • Development of accessible molecular methods enhances early and accurate DMD diagnosis.

    • Conclusions:

    • Further research into dystrophin holds promise for effective DMD treatments.
    • Improved diagnostic tools are crucial for timely intervention and management of Duchenne muscular dystrophy.